🔎 Trials Near Me

Hem › Crohns sjukdom › Georgia › Atlanta

Kliniska studier för Crohns sjukdom i Atlanta, GA

17 studier för Crohns sjukdom söker deltagare vid platser i och runt Atlanta (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.

Officiell studietext (engelska)

Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

RekryterarFas 3
  • Morehouse School Of Medicine ( Site 5071), Atlanta
Ålder 16 till 80 · Alla kön · Uppdaterad 2 okt. 2026 · NCT06430801

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

RekryterarFas 4
  • Digestive Healthcare of Georgia, Atlanta
  • AGA GA Research LLC, Atlanta
Ålder 18 till 80 · Alla kön · Uppdaterad 30 sep. 2026 · NCT06581328

A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

RekryterarFas 3
  • Emory University, Atlanta
  • Children's Center for Digestive Health Care, Atlanta
Ålder 2 till 17 · Alla kön · Uppdaterad 25 sep. 2026 · NCT05923073

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

RekryterarFas 2
  • Emory University Hospital, The Emory Clinic, Atlanta
  • Atlanta Center For Gastroenterology, P.C., Decatur · 6 mi bort
Ålder 18 till 75 · Alla kön · Uppdaterad 25 sep. 2026 · NCT06233461

A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

RekryterarFas 3
  • Morehouse School of Medicine, Atlanta
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT07499232

A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants

RekryterarFas 3
  • Emory University, Atlanta
  • Children's Center for Digestive Healthcare, Atlanta
Ålder 3 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT06663332

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

RekryterarFas 2/3
  • Emory University, Atlanta
  • Children's Center for Digestive Health Care, Atlanta
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT07196722

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

RekryterarFas 3
  • Atlanta Gastroenterology Associates-Site Number: 8400109, Atlanta
Ålder 16 till 80 · Alla kön · Uppdaterad 23 sep. 2026 · NCT07184931

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

RekryterarFas 3
  • Emory University School of Medicine, Atlanta
  • Children's Center for Digestive Health Care, LLC, Atlanta
Ålder 2 till 19 · Alla kön · Uppdaterad 22 sep. 2026 · NCT04844606

A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease

RekryterarFas 2
  • Atlanta Gastroenterology Associates - Peachtree Dunwoody, Atlanta
Ålder 18 till 80 · Alla kön · Uppdaterad 22 sep. 2026 · NCT07483099

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

RekryterarFas 2
  • Atlanta Gastroenterology Specialists, PC, Atlanta
  • Atlanta Gastroenterology Associates (Part of United Digestive), Atlanta
Ålder 18 till 85 · Alla kön · Uppdaterad 22 sep. 2026 · NCT06226883

A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

RekryterarFas 2
  • Atlanta Gastroenterology Associates - Peachtree Dunwoody, Atlanta
Ålder 18 till 80 · Alla kön · Uppdaterad 22 sep. 2026 · NCT07483073

A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease

RekryterarFas 3
  • Emory University, Atlanta
  • Children's Center for Digestive Health Care, LLC, Atlanta
Ålder 2 till 17 · Alla kön · Uppdaterad 24 aug. 2026 · NCT05509777

Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease

RekryterarFas 4
  • Emory University, Atlanta
Ålder 6 till 17 · Alla kön · Uppdaterad 27 maj 2026 · NCT05781152

A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)

RekryterarFas 3
  • Childrens Center For Digestive Healthcare, Atlanta
Ålder 2 och äldre · Alla kön · Uppdaterad 7 maj 2026 · NCT05442567

A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)

RekryterarFas 3
  • Childrens Center For Digestive Healthcare, Atlanta
Ålder 2 till 17 · Alla kön · Uppdaterad 5 maj 2026 · NCT04779320

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

RekryterarFas 2
  • Mirador Therapeutics Selected Site, Atlanta
Ålder 18 till 80 · Alla kön · Uppdaterad 12 mars 2026 · NCT07113522

Crohns sjukdom-studier i andra städer

Andra studier i Atlanta

Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.